CR:DOI:ee68d2935f07f1456c07b4a6efab4f88: Difference between revisions
From IDWiki
Content deleted Content added
Created page with "{{#scite: |reference=rybak2020th |type=article-journal |title=Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A rev..." |
(No difference)
|
Latest revision as of 14:57, 4 April 2020
{{#scite:
|reference=rybak2020th
|type=article-journal
|title=Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists
|author=Michael J Rybak;Jennifer Le;Thomas P Lodise;Donald P Levine;John S Bradley;Catherine Liu;Bruce A Mueller;Manjunath P Pai;Annie Wong-Beringer;John C Rotschafer;Keith A Rodvold;Holly D Maples;Benjamin M Lomaestro|+sep=;
|journal=American Journal of Health-System Pharmacy
|publisher=Oxford University Press (OUP)
|year=2020
|doi=10.1093/ajhp/zxaa036
|subject=Health Policy;Pharmacology|+sep=;
|issn=1079-2082;1535-2900|+sep=;
|retrieved-from=https://dx.doi.org/
|retrieved-on=2020-04-04
}}
